Cargando…

Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis

Neuroaxonal degeneration in the central nervous system contributes substantially to the long term disability in multiple sclerosis (MS) patients. However, in vivo determination and monitoring of neurodegeneration remain difficult. As the widely used MRI-based approaches, including the brain parenchy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dörr, Jan, Wernecke, Klaus D., Bock, Markus, Gaede, Gunnar, Wuerfel, Jens T., Pfueller, Caspar F., Bellmann-Strobl, Judith, Freing, Alina, Brandt, Alexander U., Friedemann, Paul
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072966/ https://www.ncbi.nlm.nih.gov/pubmed/21494659 http://dx.doi.org/10.1371/journal.pone.0018132

Ejemplares similares

Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis
por: Pfueller, Caspar F., et al.
Publicado: (2011)

Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)
por: Bäcker-Koduah, Priscilla, et al.
Publicado: (2020)

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue
por: Gaede, Gunnar, et al.
Publicado: (2017)

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008)

High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
por: Dörr, Jan, et al.
Publicado: (2020)

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study
por: Wieder, Laura, et al.
Publicado: (2013)

Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial
por: Rust, Rebekka, et al.
Publicado: (2021)

Exercise in multiple sclerosis -- an integral component of disease management
por: Döring, Andrea, et al.
Publicado: (2011)

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)

Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial
por: Dörr, Jan, et al.
Publicado: (2018)

Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study
por: Klumbies, Katharina, et al.
Publicado: (2021)

Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis)
por: Veauthier, Christian, et al.
Publicado: (2015)

Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data
por: Veauthier, Christian, et al.
Publicado: (2016)

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
por: Borisow, Nadja, et al.
Publicado: (2012)

Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration
por: Brandt, Alexander U., et al.
Publicado: (2021)

Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
por: Schwichtenberg, Svenja C., et al.
Publicado: (2021)

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
por: Veauthier, Christian, et al.
Publicado: (2015)

MRI Pattern Recognition in Multiple Sclerosis Normal-Appearing Brain Areas
por: Weygandt, Martin, et al.
Publicado: (2011)

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
por: Blindenbacher, Nelly, et al.
Publicado: (2020)

Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS
por: Bäcker‐Koduah, Priscilla, et al.
Publicado: (2020)

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
por: Rasche, Ludwig, et al.
Publicado: (2016)

Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2020)

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
por: Behrens, Janina R., et al.
Publicado: (2018)

Imaging the Visual Pathway in Neuromyelitis Optica
por: Pfueller, Caspar F., et al.
Publicado: (2011)

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
por: Gieß, René M., et al.
Publicado: (2017)

Optical coherence tomography for retinal imaging in multiple sclerosis
por: Zimmermann, Hanna, et al.
Publicado: (2014)

Brain Viscoelasticity Alteration in Chronic-Progressive Multiple Sclerosis
por: Streitberger, Kaspar-Josche, et al.
Publicado: (2012)

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
por: Rosche, Berit, et al.
Publicado: (2013)

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019)

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis
por: Cooper, Graham, et al.
Publicado: (2019)

Temporal visual resolution and disease severity in MS
por: Ayadi, Noah, et al.
Publicado: (2018)

Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study
por: Drebinger, Daniel, et al.
Publicado: (2020)

Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis
por: Schließeit, Jana, et al.
Publicado: (2020)

Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2021)

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis
por: Millward, Jason M., et al.
Publicado: (2020)

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD
por: Oertel, Frederike C., et al.
Publicado: (2017)

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
por: Cooper, Graham, et al.
Publicado: (2021)

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life
por: Krüger, Theresa, et al.
Publicado: (2017)

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing
por: Grobelny, Anuschka, et al.
Publicado: (2017)

Prefrontal-amygdala emotion regulation and depression in multiple sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_740os3vjdkj7jjndspqs7m6hrk